Analytics cookies help us understand what works in the catalog. Accept all, reject non-essential ones, or choose categories below. Privacy policy
GHRP-2 (Pralmorelin) — a research peptide, a growth-hormone secretagogue and ghrelin-receptor agonist (a peptide ghrelin-mimetic), studied for stimulating pulsatile GH release in research models. Lyophilized powder, an independent COA per batch, purity ≥99%.
Size: 10 mg
No published analyses yet.
Titration schedule · reference
The information below is provided from public sources for reference only. It is not advice or instructions for use; products are intended for laboratory research only and not for human consumption.
| Period / condition | Dose | Escalation |
|---|---|---|
| Start | 100 mcg, once daily | Starting dose |
| Standard regimen | 100–200 mcg, 1–3x/day | Increase if needed |
| Maximum in this schedule | up to 300 mcg (≈3–4 mcg/kg at 70–100 kg body weight) per injection, 2–3x/day | Maximum in this schedule |
Share your experience
No reviews yet. Tell others what you think of this product.
GHRP-2 (pralmorelin) is a peptide growth-hormone secretagogue that acts through the ghrelin receptor. Research into muscle growth, recovery, and body composition uses it as a tool for driving pulsatile GH release, independent of the hypothalamic GHRH pathway. Its appetite-stimulating effect runs noticeably milder than GHRP-6's, which is why some labs reach for it when GH stimulation is the goal without a strong hunger response.
Longeva supplies GHRP-2 as a research substance: a lyophilized powder with an independent certificate of analysis (COA, HPLC) per batch and a stated purity of ≥99%.
